Atıf İçin Kopyala
Kup A., Kanar B., Uslu A., Zehir R., Akaslan D., KEPEZ A.
MARMARA MEDICAL JOURNAL, cilt.35, sa.1, ss.36-41, 2022 (ESCI)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
35
Sayı:
1
-
Basım Tarihi:
2022
-
Doi Numarası:
10.5472/marumj.1056187
-
Dergi Adı:
MARMARA MEDICAL JOURNAL
-
Derginin Tarandığı İndeksler:
Emerging Sources Citation Index (ESCI), Scopus, Academic Search Premier, CINAHL, EMBASE, TR DİZİN (ULAKBİM)
-
Sayfa Sayıları:
ss.36-41
-
Anahtar Kelimeler:
Statin treatment, Percutaneous transluminal angioplasty, Peripheral artery disease, RISK-FACTORS, ATORVASTATIN, OUTCOMES, METAANALYSIS, SIMVASTATIN, ANGIOPLASTY
-
Marmara Üniversitesi Adresli:
Evet
Özet
Aim: Statins are one of the most important agents in the treatment of atherosclerotic peripheral arterial disease. We aim to compare high - and moderate-dose stain therapy in patients with lower extremity artery disease (LEAD) who have undergone percutaneous transluminal angioplasty (PTA).